skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:034373/0577   Pages: 23
Recorded: 11/20/2014
Attorney Dkt #:300614-148 NEPHROGENEX
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 6
1
Patent #:
Issue Dt:
05/08/2007
Application #:
11054527
Filing Dt:
02/09/2005
Publication #:
Pub Dt:
12/08/2005
Title:
METHODS FOR THE SYNTHESIS OF PYRIDOXAMINE
2
Patent #:
Issue Dt:
11/29/2011
Application #:
12019819
Filing Dt:
01/25/2008
Publication #:
Pub Dt:
05/22/2008
Title:
PYRIDOXAMINE FOR THE TREATMENT OF DIABETIC INTERMEDIARIES AND POST-AMADORI INHIBITION
3
Patent #:
Issue Dt:
04/30/2013
Application #:
12855108
Filing Dt:
08/12/2010
Publication #:
Pub Dt:
12/02/2010
Title:
Methods for the Synthesis of Pyridoxamine
4
Patent #:
NONE
Issue Dt:
Application #:
13935791
Filing Dt:
07/05/2013
Publication #:
Pub Dt:
11/07/2013
Title:
Pyridoxamine for the Treatment of Diabetic Kidney Disease
5
Patent #:
Issue Dt:
08/30/2016
Application #:
14184888
Filing Dt:
02/20/2014
Publication #:
Pub Dt:
07/03/2014
Title:
Inhibitors of Advanced Glycation End Products
6
Patent #:
NONE
Issue Dt:
Application #:
14185312
Filing Dt:
02/20/2014
Publication #:
Pub Dt:
06/19/2014
Title:
Pyridoxamine for the Treatment of Diabetic Kidney Disease
Assignor
1
Exec Dt:
11/20/2014
Assignee
1
2350 MISSON COLLEGE BLVD., SUITE 988
SANTA CLARA, CALIFORNIA 95054
Correspondence name and address
COOLEY LLP
101 CALIFORNIA STREET, 5TH FLOOR
SAN FRANCISCO, CA 94111

Search Results as of: 06/22/2024 08:40 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT